Last month, MIT Science and Technology Review released the report "AI Medical Care: Asia's Development Space, Capability and Active and Healthy Future" (hereinafter referred to as the "Report"), pointing out that AI is rising in the medical field in Asia to meet its regional needs and challenges.
The Report evaluates the application value and prospect of AI in Asian medical services through interviews, research and field visits to experts and leading enterprises in the medical field in Asian countries.
According to the report, many countries in Asia are facing the shortage of medical resources in the context of the shortage of medical human resources. According to the data of the World Health Organization, by 2030, there will be more than120,000 medical practitioners in Asia, an increase of more than 70%. Secondly, insufficient medical expenditure is another serious challenge. Except for developed economies, the per capita medical expenditure in other Asian countries and regions is less than a quarter of the standard of the Organization for Economic Cooperation and Development (OECD). Artificial intelligence technology is effectively narrowing the gap in medical development in Asia.
The medical development in Asia is benefiting from the great help of front-line medical staff under AI technology and the professional assistance brought by new diagnosis and treatment methods such as "human-computer interaction". In addition, many countries in Asia also aim at "responding to their own medical challenges" and rapidly promote AI innovation through public-private cooperation. Whether it is Singapore's efforts to reduce "hyperlipidemia, hyperglycemia and hypertension" by using AI technology, India's efforts to reduce infant mortality, or Japan's application in the aging problem, Asia's AI application in the medical field is full of urgent needs and huge market.
Talking about using AI to improve the supply capacity of medical services in Asia and alleviate the shortage of medical resources, the report takes an Internet company in China as an example to introduce its AI-driven "Clinical Assistant Decision System" (CDSS). At present, the system has covered nearly 1,000 medical institutions in 16 provinces, municipalities and autonomous regions, and assisted doctors in making clinical diagnosis decisions through standardized diagnosis procedures and scientific treatment scheme recommendation.
The report also points out the importance of preventive diagnosis and treatment strategies in view of the development trend of AI medical care in Asia. In the future, the medical ecosystem will pay more attention to health and well-being, and AI will play a leading role in promoting "active health" by identifying disease symptoms and tracking health status; At the same time, the medical system must adhere to the people-oriented principle. From an ethical point of view, science and technology must be an auxiliary tool for doctors and medical practitioners. In order to ensure the accountability of the medical system, the final decision-making power must be firmly in the hands of people. AI developers should ensure that doctors and patients can accurately interpret and understand technology, so that doctors and patients will continue to trust technology and be willing to use artificial intelligence in the medical field.
Asian Wave, Boao Vision
"Be based in Asia and face the world"
Pass on the latest developments of the forum and promote in-depth cooperation in Asia.
The disseminator of important global dialogues and the watcher of Asian development.